Related Experiment Video
Updated: Jul 29, 2025
09:02
Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
Published on: June 5, 2020
7.5K
Liver Organoid Potential Application for Hepatitis E Virus Infection.
1Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China. kxiang@bjmu.edu.cn.
Advances in Experimental Medicine and Biology
|May 24, 2023
Summary
Hepatitis E virus (HEV) research is limited by low infection rates in cell models. Liver organoids offer a promising new system to study HEV infection, replication, and develop antiviral drugs.
Area of Science:
- Hepatology
- Virology
- Regenerative Medicine
Background:
- Current cell culture models exhibit low hepatitis E virus (HEV) infection efficacy.
- This limitation hinders comprehensive studies on HEV infection mechanisms, replication, and host interactions.
Purpose of the Study:
- To explore the potential of liver organoids as an advanced cell culture system for HEV infection studies.
- To discuss the application of liver organoids in understanding HEV pathogenesis and facilitating antiviral drug discovery.
Main Methods:
- Liver organoids are generated from adult tissue biopsies or induced pluripotent stem cells (iPSCs)/embryonic stem cells (ESCs).
- These organoids recapitulate the liver's microenvironment with multiple cell types.
Main Results:
- Liver organoids provide a scalable platform for experiments, including antiviral drug screening.
- The complex cellular composition supports cell morphogenesis, migration, and response to viral challenges.
Conclusions:
- Optimizing liver organoid generation protocols will accelerate HEV research.
- Liver organoids show significant potential for advancing the study of HEV infection, pathogenesis, and antiviral therapies.
